The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipients.
Lymphocyte phosphoglucomutase can be used as a genetic marker to document successful engraftment in bone marrow transplant recipients. Two patients who underwent marrow transplantation as a treatment for acute leukemia showed a change into donor-type isozyme pattern.
D000208:Acute Disease; D016026:Bone Marrow Transplantation; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D007938:Leukemia / Q000628:therapy; D008214:Lymphocytes / Q000201:enzymology*; D008297:Male; D010733:Phosphoglucomutase; D014184:Transplantation, Homologous
D007527:Isoenzymes; D010733:Phosphoglucomutase